Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.

Rieger, Max J; Stolz, Sebastian M; Ludwig, Sabine; Benoit, Tobias M; Bissig, Marina; Widmer, Corinne C; Schwotzer, Rahel; Müller, Antonia M; Nair, Gayathri; Hegemann, Inga; Manz, Markus G; Schanz, Urs

Rieger, Max J; Stolz, Sebastian M; Ludwig, Sabine; Benoit, Tobias M; Bissig, Marina; Widmer, Corinne C; Schwotzer, Rahel; Müller, Antonia M; Nair, Gayathri; Hegemann, Inga; Manz, Markus G; Schanz, Urs.

Afiliación

Rieger MJ; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Stolz SM; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Ludwig S; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Benoit TM; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Bissig M; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Widmer CC; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Schwotzer R; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Müller AM; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Nair G; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Hegemann I; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Manz MG; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Schanz U; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.

Br J Haematol ; 194(5): 931-934, 2021 09.

Article en En | MEDLINE | ID: mdl-34180543

Asunto(s)

Anemia Hemolítica Autoinmune/tratamiento farmacológico; Anticuerpos Monoclonales/uso terapéutico; Factores Inmunológicos/uso terapéutico; Rituximab/uso terapéutico; Adulto; Femenino; Humanos; Masculino; Persona de Mediana Edad; Estudios Retrospectivos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rituximab / Factores Inmunológicos / Anemia Hemolítica Autoinmune / Anticuerpos Monoclonales Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google